Novel Therapy Shows Promise for Aggressive Lymphoma Resistant to Immunotherapy
News Context
At a glance
- * Title: Priming with DNMT Inhibitors Potentiates PD-1 Immunotherapy by Triggering Viral Mimicry in Relapsed/Refractory NK/T-cell lymphoma * Journal: Cancer Discovery * DOI: 10.1158/2159-8290.CD-25-0587 * publication Year:...
- * Provided by: American Association for Cancer Research (AACR) * AACR Website: http://www.aacr.org/default.aspx
- * Title: Novel combination therapy shows promise for aggressive lymphoma resistant to immunotherapy * Date of Publication: October 15, 2025 * Date of Retrieval: October 15, 2025...
Here’s a breakdown of the details provided in the text:
Research Article:
* Title: Priming with DNMT Inhibitors Potentiates PD-1 Immunotherapy by Triggering Viral Mimicry in Relapsed/Refractory NK/T-cell lymphoma
* Journal: Cancer Discovery
* DOI: 10.1158/2159-8290.CD-25-0587
* publication Year: 2025
Source:
* Provided by: American Association for Cancer Research (AACR)
* AACR Website: http://www.aacr.org/default.aspx
News Article Information:
* Title: Novel combination therapy shows promise for aggressive lymphoma resistant to immunotherapy
* Date of Publication: October 15, 2025
* Date of Retrieval: October 15, 2025 (This is the date the information was accessed/recorded)